Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Discovery & Development

Wasps Versus Cancer

Researchers have known for some time that Polybia paulista wasp venom contains an ingredient that selectively kills some cancer cells, but the big mystery is how exactly the agent works. Motivated to investigate the venom further, Paul Beales, a senior research fellow at the University of Leeds, and João Ruggiero Neto, a professor of physics at São Paulo State University, Brazil, believe they have uncovered a molecule with a mechanism of action that is distinct to any current anticancer drug (1). We spoke to Beales to learn more about the science behind the sting.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE!

Login

Or register now - it’s free!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

When you click “Register” we will email you a link, which you must click to verify the email address above and activate your account. If you do not receive this email, please contact us at [email protected].

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register